| Literature DB >> 34027484 |
Ayse Seda Yazgili1, Thomas Meul1, Vanessa Welk1, Nora Semren1, Ilona E Kammerl1, Silke Meiners1.
Abstract
This protocol describes an easy and reliable in-gel proteasome assay to quantify the activity and composition of different proteasome complexes in cells and tissues. The assay works well with limited amounts of total cell protein lysates. Although this assay is optimized specifically for the proteasome chymotrypsin-like activity, it can be expanded to other proteasome activities as well. Using antibodies that detect distinct proteasome subunits or regulators, we can determine the composition and relative quantity of active proteasome complexes. For complete details on the use and execution of this protocol, please refer to Meul et al. (2020).Entities:
Keywords: Antibody; Cell Biology; Molecular Biology; Protein Biochemistry
Mesh:
Substances:
Year: 2021 PMID: 34027484 PMCID: PMC8121766 DOI: 10.1016/j.xpro.2021.100526
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Comparison of OK Lysis Buffer and TSDG Lysis Buffer
We used OK Lysis Buffer (1) and TSDG Lysis Buffer (2) conditions to lyse the cells grown under the same conditions and loaded equal amounts of protein onto the gel. The left panel shows the chymotrypsin-like activity of the proteasome complexes, while the right panel shows the immunoblotting of the same gel with α1-7 antibody. There is not apparent difference in proteasome activity and composition when using the two different lysis buffer conditions.
Figure 2Re-using same membrane for probing with two different primary antibodies
A549 cells were treated with IFNγ+TNFα (10 ng/mL and 20 ng/mL, respectively, for 24 h). The first lane (1) contains native lysates from control cells, the second lane (2) contains lysates prepared from A549 cells treated with inflammatory cytokines. After the in-gel proteasome activity assay (left panel), the gel was immunoblotted and incubated with anti-MECL-1 antibody (middle panel). The same membrane was used for detection of LMP2, a second catalytic subunit of the immunoproteasome (right panel). Since both antibodies were from the same species (rabbit) the membrane was incubated with the secondary antibody after stripping/blocking and imaged. The anti-LMP2 antibody was added to the membrane upon confirmation that MECL-1 was not detectable anymore.
Figure 3Changes in the activity, amount, and composition of proteasome complexes upon treatment
A549 cells were treated with IFNγ+TNFα (10 ng/mL and 20 ng/mL, respectively, 24 h). The first lane (1) contains native lysates from control cells, the second lane (2) contains lysates prepared from A549 cells treated with inflammatory cytokines.
(A–C) (A) In-gel proteasome activity assay, (B) Immunoblotting of the same native gel and probing of the membrane with anti-α1-7 antibody, (C) Quantification of α1-7 levels in different proteasome complexes (30S, 26S and 20S).
Quantification of immunoblots of native gels, as used in Figure 3B
| Lane | Band No. | Band label | Mol. Wt. (KDa) | Relative front | Adj. volume (Int) | Volume (Int) | Abs. quant. | Rel. quant. | Band % | Lane % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30S (Control) | N/A | 0.14881 | 2015172 | 2571291 | N/A | N/A | 10.52189 | 3.957284 | ||
| 26S (Control) | N/A | 0.205357 | 5222826 | 5961843 | N/A | N/A | 27.27014 | 10.2563 | ||
| 20S (Control) | N/A | 0.5 | 11914182 | 12954654 | N/A | N/A | 62.20797 | 23.39642 | ||
| 30S (Treatment) | N/A | 0.151786 | 1240542 | 1870884 | N/A | N/A | 5.022063 | 2.204661 | ||
| 26S (Treatment) | N/A | 0.199405 | 6978366 | 7735419 | N/A | N/A | 28.25039 | 12.40178 | ||
| 20S (Treatment) | N/A | 0.497024 | 16482933 | 17678250 | N/A | N/A | 66.72755 | 29.29307 |
Upon quantification of activity and amount of proteasome complexes, you can determine the specific activity as outlined above as well as the ratio of complexes. The ratio will give you information about any alterations in proteasome complex assembly or disassembly upon treatment.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Anti-Proteasome 20S alpha 1+2+3+5+6+7 Antibody (1:1000) | Abcam | Cat# ab22674; RRID: |
| Anti-TBP1 (RPT5) Antibody (1:5000) | Bethyl Laboratories | Cat# A303-538A |
| Anti-Proteasome 20S α4 subunit (human), mAb (MCP34) antibody (1:2000) | Enzo Life Sciences | Cat# BML-PW8120 |
| Anti-PSMB5 antibody (1:1000) | Abcam | Cat# ab90867 |
| Anti-PSMD11 Antibody (1:1000) | Novus Biologicals | Cat# |
| Anti-PSME1 antibody (1:1000) | Abcam | Cat# ab155091 |
| Anti-PA28γ Antibody (1:1000) | Santa Cruz Biotechnology | Cat# sc-136025 |
| Anti-Proteasome activator 11S γ subunit antibody (1:2000) | Enzo Life Sciences | Cat# BML-PW8190 |
| Anti-PA200 Antibody (1:1000–1:2500) | Novus Biologicals | Cat# NBP2-22236 |
| Anti-mouse IgG HRP-linked Antibody (1:10000–1:40000) | Cell Signaling | Cat# 7076 |
| Anti-rabbit IgG HRP-linked Antibody (1:10000–1:40000) | Cell Signaling | Cat# 7074 |
| Suc-Leu-Leu-Val-Tyr-AMC | Bachem | I-1395.0100; CAS: 94367-21-2 |
| cOmplete™ Protease Inhibitor | Roche | Ref# 11697498001 |
| Adenosine triphosphate (ATP) | Roche Diagnostics | Ref# BP413-25 |
| Dithiothreitol (DTT) | Life Technologies | Ref# A2948, 0025 |
| Pierce BCA Protein Assay Kit | Thermo Fisher Scientific | Ref# 23225 |
| Immobilon Classico Western HRP substrate | Merck Millipore | Ref# WBLUC0500 |
| Immobilon Forte Western HRP substrate | Merck Millipore | Ref# WBLUF0500 |
| Image Lab 6.1 | Bio-Rad | https:// |
| NuPAGE 3%–8% Tris-Acetate gel | NOVEX Life Technologies | EA0378BOX |
| Gel Doc™ EZ System | Bio-Rad | 1708270EDU |
| iBright™ CL1500 Imaging System | Invitrogen | A44114 |
| Balance | Mettler Toledo | XS205 |
TSDG Lysis Buffer
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris/HCl (100 mM) | 10 mM | 1 mL |
| MgCl2 (10 mM) | 1.1 mM | 1.1 mL |
| NaCl (1 M) | 10 mM | 100 μL |
| EDTA (50 mM) | 0.1 mM | 20 μL |
| NaN3 (100 mM) | 1 mM | 100 μL |
| DTT (1 M) | 1 mM | 10 μL |
| ATP (200 mM) | 2 mM | 100 μL |
| Glycerol (87%) | 10% (v/v) | 1.15 mL |
| ddH2O | n/a | 6.57 mL |
To avoid freeze and thaw cycles of the TSDG Lysis Buffer, aliquot it upon preparation into smaller batches and keep it at −20°C until further use. We suggest preparing 10 mL TSDG Lysis Buffer to avoid storing it for longer time. We do not defrost aliquots more than two times, as this might affect the stability of DTT and ATP in the buffer.
OK Lysis Buffer
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris/HCl (pH 7.5, 100 mM) | 50 mM | 5 mL |
| DTT (1 M) | 2 mM | 20 μL |
| MgCl2 (1 M) | 5 mM | 50 μL |
| Glycerol (87%) | 10% (v/v) | 1.15 mL |
| ATP | 2 mM | 12 mg |
| Digitonin (5%) | 0.05% (v/v) | 100 μL |
| ddH2O | n/a | Add up to 10 mL |
To avoid freeze and thaw cycles of the OK Lysis Buffer, aliquot it into smaller batches and keep it at −20°C until further use. We suggest preparing 10 mL OK Lysis Buffer to avoid storing it for longer time. We do not defrost aliquots more than two times, as this might affect the stability of DTT and ATP in the buffer.
8× TBE buffer pH 8.3
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris Base | 712 mM | 86. 4 |
| Boric Acid | 712 mM | 44 |
| EDTA-Na2 | 16 mM | 5.6 |
| ddH2O | n/a | Add up to 1 L |
8× TBE Buffer can be stored at 20°C–23°C for 6 months.
5× native gel loading buffer
| Reagent | Final concentration | Amount |
|---|---|---|
| Bromophenol Blue | 0.05% (w/v) | 2.5 mg |
| Glycerol (87%) | 43.5% | 2.5 mL |
| Tris (pH 7.5, 500 mM) | 250 mM | 2.5 mL |
250× ATP/MgCl2
| Reagent | Final concentration | Amount |
|---|---|---|
| MgCl2∗6H2O | 2.5 M | 1.0165 |
| ATP | 250 mM | 0.3026 |
| ddH2O | n/a | Add up to 2 mL |
Native gel running buffer
| Reagent | Final concentration | Amount |
|---|---|---|
| TBE Buffer (8×) | 1× | 100 mL |
| ATP | 413 μM | 200 mg |
| MgCl2 (1 M) | 2 mM | 1.6 mL |
| DTT (1 M) | 0.5 mM | 400 μL |
| ddH2O | n/a | Add up to 800 mL |
| DS | DS | S#1 | S#2 | S#3 | S#4 | S#5 | S#6 | S#7 | S#8 | S#9 | S#10 | DS | DS | DS |
Reaction buffer for in-gel proteasome activity assay
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris (pH 7.5, 100 mM) | 1× | 12.5 mL |
| ATP/ MgCl2 (250×) | 1× | 100 μL |
| DTT (1 M) | 1 mM | 25 μL |
| Suc-LLVY-AMC (2 mM, dissolved in DMSO) | 48 μM | 600 μL |
| ddH2O | n/a | 11.775 mL |
Solubilization buffer
| Reagent | Final concentration | Amount |
|---|---|---|
| SDS | 2% (w/v) | 10 |
| Na2CO3 | 66 mM | 3.5 |
| β-Mercaptoethanol | 1.5% (v/v) | 7.5 mL |
| ddH2O | n/a | Add up to 500 mL |